Tue, Aug 4, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Alternative mutual funds are here to stay

Wednesday, September 18, 2013

Bailey McCann, Opalesque New York:

Much has been written about hedged mutual funds, leading some to call them a new fad for retail investors. However, more and more managers are looking at mutual fund structures, and Tom Florence, CEO of Denver-based 361 Capital, says they are here to stay. 361 was founded in 2001, and was one of the early entrants to the liquid alternatives space, the firm manages three alternative mutual funds including a managed futures product. That fund - the flagship - currently has $415m in assets, and firm assets are at $460m.

"Mutual funds are a hard business, and they are a really different business, so hedge fund managers have to decide if they are going to go it alone or if they are going to do it with a partner who understands," he says in an interview with Opalesque, noting that there is an underserved investor marketplace for these products.

"The challenge is there are only so many alternative assets - is there enough room for all of these funds? No. So you're going to see focus on quality and performance."

Some early entrants into the space that lack quality may have a hard time competing against newer, higher quality products entering the market, he says. This also holds true for other retail avenues into the alternatives industry like business development companies (BDCs), or closed-end funds.

"The other interesting thing that I think you'll start to see happen is, a lot of hedge fun......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner